abstract |
THE INVENTION CONCERNS NEW COMPOUNDS MODULATING SIRTUINS AND THEIR METHODS OF USE. THESE SIRTUIN-MODULATING COMPOUNDS MAY BE USED TO EXTEND THE LIFE OF A CELL AND TO TREAT AND / OR PREVENT A LARGE NUMBER OF DISEASES AND DISORDERS, INCLUDING, FOR EXAMPLE, DISEASES AND DISORDERS RELATED TO AGING AND STRESS, DIABETES, OBESITY, NEURODEGENERATIVE DISEASES, CARDIOVASCULAR DISEASE, BLOOD COAGULATION DISORDERS, INFLAMMATION, CANCER, AND / OR VASOMOTRIC IMPACT, AS WELL AS DISEASES OR DISORDERS WHICH MAY ENJOY MITOCHONDRIAL ACTIVITY MORE INTENSE. The invention also relates to compositions comprising a SIRTUIN-MODULATING COMPOUND, COMBINED WITH ANOTHER THERAPEUTIC AGENT. |